March 2018 - Page 28 of 48 - NetworkNewsWire

MondayMar 12, 2018 4:30 pm

TransAct Technologies, Inc. (NASDAQ: TACT) Starts Presentation at 30th Annual ROTH Conference

TransAct Technologies (NASDAQ: TACT) develops software-driven technology and printing solutions for high-growth markets such as restaurant solutions, POS automation, casino and gaming, lottery, mobile, and oil and gas. TransAct’s solutions are created from the ground up based on customer requirements and are sold under the AccuDate™, EPICENTRAL®, Epic®, Ithaca®, RESPONDER and Printrex® brands. The company has installed more than 3 million printers and terminals throughout the world and is dedicated to offering world-class service, spare parts and accessories to support its installed product base. Additionally, the company offers a full range of supplies and consumable items, both online and through…

MondayMar 12, 2018 4:30 pm

Layne Christensen Co. (NASDAQ: LAYN) Starts Presentation at 30th Annual ROTH Conference

Layne Christensen (NASDAQ: LAYN) is a global water management, construction, and drilling company that provides responsible solutions for water, mineral and energy challenges. The Woodlands, Texas-based company operates throughout North America, Africa, Australia, Europe, Brazil, and in other South American countries through its affiliates. Layne solutions comprise of identifying and developing a new water source, delivering usable water to communities and facilities around the world, recycling water from oil and gas resources, rehabilitating an existing pipeline, or safely returning wastewater to the natural environment. For more information, visit the company’s website at www.layne.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

MondayMar 12, 2018 4:30 pm

Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) Starts Presentation at 30th Annual ROTH Conference

Ligand Pharmaceuticals (NASDAQ: LGND) is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The company’s Captisol® platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. OmniAb® is a patent-protected transgenic animal platform used in the discovery of fully human mono- and bispecific therapeutic antibodies. The company partners with other pharmaceutical companies to ultimately generate further revenue. Such alliances, licenses and other business relationships include Novartis, Amgen, Merck, Pfizer, Celgene, Gilead, Janssen, Baxter International and Eli Lilly. For more information, visit the company’s website…

MondayMar 12, 2018 4:30 pm

DMC Global, Inc. (NASDAQ: BOOM) Starts Presentation at 30th Annual ROTH Conference

DMC Global (NASDAQ: BOOM) operates in two sectors: industrial infrastructure and oilfield products and services. The industrial infrastructure sector is served by DMC’s NobelClad business, the world’s largest manufacturer of explosion-welded clad metal plates, which are used to fabricate capital equipment utilized within various process industries and other industrial sectors. The oilfield products and services sector is served by DynaEnergetics, an international developer, manufacturer and marketer of advanced explosive components and systems used to perforate oil and gas wells. For more information, visit the company’s website at www.dmcglobal.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

MondayMar 12, 2018 4:30 pm

The Ultimate Software Group, Inc. (NASDAQ: ULTI) Starts Presentation at 30th Annual ROTH Conference

The Ultimate Software Group (NASDAQ: ULTI) provides human capital management (HCM) solutions in the cloud and has more than 37 million people records in the Ultimate cloud. The company’s award-winning UltiPro provides HR, payroll, talent, and time and labor management solutions that connect people with the information they need to work more effectively. Ultimate has been the recipient of many prestigious awards, including being ranked No. 3 by Fortune for 2018 on its “100 Best Companies to Work For” and No. 1 in the Large Company category on its “40 Best Workplaces in Technology” list. The company serves more than…

MondayMar 12, 2018 4:30 pm

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Starts Presentation at 30th Annual ROTH Conference

Sorrento Therapeutics (NASDAQ: SRNE) is a clinical-stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Sorrento’s multimodal multipronged approach to fighting cancer is made possible by its’ extensive immuno-oncology platforms, including key assets such as fully human antibodies (“G-MAB™ library”), clinical stage immuno-cellular therapies (“CAR-T”), intracellular targeting antibodies (“iTAbs”), antibody-drug conjugates (“ADC”), and clinical stage oncolytic virus (“Sephrevir®”). Sorrento’s commitment to life-enhancing therapies for cancer patients is also demonstrated by our effort to advance a first-in-class (TRPV1 agonist) non-opioid pain management small molecule in Resiniferatoxin (“RTX”) and ZTlido. Resiniferatoxin is completing a…

MondayMar 12, 2018 4:13 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Linker Tech Mimics Body’s Production of Pain Relieving Peptides

Developing pain relievers that mimic body’s natural pain relief peptides Other programs include development of treatments for diabetes, synthetization of blue scorpion venom and study of a novel cannabinoid delivery platform Revenues from international licensing strategy The discovery of endomorphins in 1997 was a remarkable reminder of the human body’s wondrous nature. Endomorphins are naturally produced morphine-like substances with an affinity for the µ-opioid receptors in the brain, which fortunately happen to be the best places to alleviate pain. With a potency that far exceeds morphine, these endogenous substances are the body’s first line of defense against pain and stress.…

MondayMar 12, 2018 4:00 pm

EMCORE Corp. (NASDAQ: EMKR) Starts Presentation at 30th Annual ROTH Conference

EMCORE (NASDAQ: EMKR) provides advanced mixed-signal optics products that provide the foundation for today’s high-speed communication network infrastructures and cutting-edge defense systems. The company’s optical chips, components, subsystems and systems enable broadband and wireless providers to continually enhance their network capacity, speed and coverage. EMCORE’s optical components and systems serve a broad array of applications including cable television, fiber-to-the-premise networks, telecommunications, wireless infrastructure, satellite RF fiber links, navigation systems and military communications. The company has fully vertically-integrated manufacturing capability through its Indium Phosphide (“InP”) wafer fabrication facility at its headquarters in Alhambra, California. For more information, visit the company’s website…

MondayMar 12, 2018 4:00 pm

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) Starts Presentation at 30th Annual ROTH Conference

AcelRx Pharmaceuticals (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The company employs its proprietary, non-invasive sublingual formulation technology that delivers sufentanil with consistent pharmacokinetic profiles. The company’s two product candidates are DSUVIA™ (known as DZUVEO outside the United States) intended to treat moderate-to-severe acute pain in medically supervised settings, and ZALVISO® which is being developed as a patient-controlled analgesia (PCA) system to reduce moderate-to-severe acute pain in medically supervised settings. For more information, visit the company's website at www.acelrx.com. About NetworkNewsWire NetworkNewsWire (NNW) is a…

MondayMar 12, 2018 4:00 pm

Hortonworks, Inc. (NASDAQ: HDP) Starts Presentation at 30th Annual ROTH Conference

Hortonworks (NASDAQ: HDP) creates, distributes and supports enterprise-ready open data platforms and modern data applications that deliver actionable intelligence from all data: data-in-motion and data-at-rest. The company is focused on driving innovation in open source communities such as Apache Hadoop, NiFi and Spark. Along with its partners, Hortonworks delivers the knowledge, training and services that allow customers to unlock transformational value for their organizations across any line of business. For more information, visit the company’s website at www.hortonworks.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: March 2018

TransAct Technologies, Inc. (NASDAQ: TACT) Starts Presentation at 30th Annual ROTH Conference

Layne Christensen Co. (NASDAQ: LAYN) Starts Presentation at 30th Annual ROTH Conference

Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) Starts Presentation at 30th Annual ROTH Conference

DMC Global, Inc. (NASDAQ: BOOM) Starts Presentation at 30th Annual ROTH Conference

The Ultimate Software Group, Inc. (NASDAQ: ULTI) Starts Presentation at 30th Annual ROTH Conference

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Starts Presentation at 30th Annual ROTH Conference

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Linker Tech Mimics Body’s Production of Pain Relieving Peptides

EMCORE Corp. (NASDAQ: EMKR) Starts Presentation at 30th Annual ROTH Conference

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) Starts Presentation at 30th Annual ROTH Conference

Hortonworks, Inc. (NASDAQ: HDP) Starts Presentation at 30th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search